Anti-Indoleamine 2, 3-dioxygenase 抗体 [SP260] - C-terminal
Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal
- KO Validated
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(9 Publications)
Knockout Tested Rabbit Recombinant Monoclonal Indoleamine 2, 3-dioxygenase antibody. C-terminal. Suitable for WB, Flow Cyt (Intra), IHC-P, ICC/IF and reacts with Human samples. Cited in 9 publications.
別名を表示する
IDO, INDO, IDO1, IDO-1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Formalin-fixed paraffin-embedded human endometrial adenocarcinoma tissue stained for Indoleamine 2 3-dioxygenase with ab228468 at 1/100 dilution in immunohistochemical analysis.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (human cervix adenocarcinoma epithelial cell) treated with 50 ng/ml IFN-gamma for 16 h cells labeling Indoleamine 2, 3-dioxygenase with purified ab228468 at 1/15 (9.4μg/ml). Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Flow cytometry analysis of HeLa cells treated with 50ng/ml IFN-gamma for 16hours labeling Indoleamine 2, 3-dioxygenase with purified ab228468 at 1/200 dilution (0.705 μg/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as a secondary antibody. Isotype control -Rabbit monoclonal IgG (ab172730) / Black. Unlableled control -Unlabelled cells / blue.Untreated cells (Green).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Formalin-fixed paraffin-embedded human colon tissue stained for Indoleamine 2 3-dioxygenase with ab228468 at 1/100 dilution in immunohistochemical analysis.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Flow Cytometry analysis of IFN-gamma treated HeLa (human epithelial cell line from cervix adenocarcinoma) cells, labeling Indoleamine 2, 3-dioxygenase with ab228468 1/400 dilution (green) compared to a negative control rabbit IgG (blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Formalin-fixed paraffin-embedded human thymus tissue stained for Indoleamine 2 3-dioxygenase with ab228468 at 1/100 dilution in immunohistochemical analysis.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Formalin-fixed paraffin-embedded human tonsil tissue stained for Indoleamine 2 3-dioxygenase with ab228468 at 1/100 dilution in immunohistochemical analysis.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Formalin-fixed paraffin-embedded human pancreatic adenocarcinoma tissue stained for Indoleamine 2 3-dioxygenase with ab228468 at 1/100 dilution in immunohistochemical analysis.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Formalin-fixed paraffin-embedded human stomach adenocarcinoma tissue stained for Indoleamine 2 3-dioxygenase with ab228468 at 1/100 dilution in immunohistochemical analysis.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Formalin-fixed, paraffin-embedded human ovarian adenocarcinoma tissue stained for Indoleamine 2, 3-dioxygenase with ab228468 at 1/100 dilution in immunohistochemical analysis.
- WB
Lab
Western blot - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (AB228468)
Western blot : Anti-IDO1 antibody [SP260] (ab228468) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab228468 was shown to bind specifically to IDO1. A band was observed at 42 kDa in treated wild-type A549 cell lysates with no signal observed at this size in IDO1 knockout cell line. To generate this image, wild-type and IDO1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal (ab228468) at 1/1000 dilution
Lane 1:
Wild-type A549 Treated IFN gamma (25 ng/mL, 48 h) ab281500 cell lysate at 20 µg
Lane 2:
Wild-type A549 Vehicle Control IFN gamma (0 ng/mL, 48 h) ab255554 cell lysate at 20 µg
Lane 3:
IDO1 knockout A549 Treated IFN gamma (25 ng/mL, 48 h) ab281489 cell lysate at 20 µg
Lane 4:
IDO1 knockout A549 Vehicle Control IFN gamma (0 ng/mL, 48 h) ab263515 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 45 kDa
Observed band size: 42 kDa
false
関連する標識済み抗体及び組成の異なる製品 (10)
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Indoleamine 2, 3-dioxygenase antibody [SP260]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal
-
Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - BSA and Azide free
-
578 PE
PE Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] (C-terminal)
-
660 APC
APC Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] (C-terminal)
-
HRP Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] (C-terminal)
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Indoleamine 2, 3-dioxygenase antibody [SP260] - C-terminal
Reactivity data
製品の詳細
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IDO plays a role in immune response regulation by degrading tryptophan an essential amino acid needed for T-cell proliferation. The depletion of tryptophan and the accumulation of its metabolites such as kynurenine cause immunosuppressive effects within the tissue microenvironment. While IDO functions mostly as a standalone enzyme its activity influences the cellular surroundings by altering the balance of local immune reactions.
Pathways
IDO integrates into the tryptophan metabolism pathway and is important in the kynurenine pathway. Through this pathway it maintains immune homeostasis and cell defense mechanisms. Proteins like kynureninase and kynurenine 3-monooxygenase also participate in the same metabolic processes which further extend the effects of tryptophan metabolism on immune cell behavior.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (9)
Recent publications for all applications. Explore the full list and refine your search
Nature medicine 29:2939-2953 PubMed37903863
2023
Applications
Unspecified application
Species
Unspecified reactive species
Hepatology international 17:927-941 PubMed37031334
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 27:5828-5837 PubMed34135021
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 2:100166 PubMed33521697
2021
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 5:eaax5851 PubMed31633026
2019
Applications
Mass Cytometry
Species
Unspecified reactive species
Cancer immunology research 7:805-812 PubMed30902819
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell 174:1373-1387.e19 PubMed30193111
2018
Applications
Mass Cytometry
Species
Unspecified reactive species
Clinical cancer research : an official journal of 24:5250-5260 PubMed30021908
2018
Applications
IHC-P
Species
Unspecified reactive species
Journal of thoracic oncology : official publicatio 13:779-791 PubMed29526824
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com